Access to care
Priority Issues
Ensuring patients have access to the highest quality patient-centered care is central to the AAN's mission. The AAN supports affordable access to telehealth services and prescription medications as part of this priority.
Drug costs and access
Prescription drug prices continue to rise. Drugs that treat complex, chronic conditions like Alzheimer's disease, Parkinson’s disease, epilepsy, and migraine, and specialty drugs that require special handling or administration, such as those used for multiple sclerosis, are particularly expensive.
The AAN supports: Action to ensure that prescription medications are accessible to patients with complex, chronic neurologic conditions; and potential solutions, which may include price negotiation and transparency.
Additional resources:
Access Monoclonal Antibodies for Alzheimer's Resources
Recent activity:
- AAN Joins Multi-society Statement on CMS' Plan to Expand the Use of Step Therapy for Medicare Part B Drugs | Posted August 4, 2025
- AAN Joins Physician-Led Letter Opposing the Ensuring Community Access to Pharmacist Services (ECAPS) Act | Posted July 24, 2025
- AAN Submits Letter of Support on MA H 1136, Prior Authorization Reform, Ahead of Committee Hearing | Posted July 7, 2025
Telehealth
The AAN believes that telehealth will continue to play an essential role in the care of patients with neurologic conditions. The AAN supports coverage of telehealth services regardless of patient location, equitable provider reimbursement, simplified state licensing requirements, and expanded telehealth research and quality initiatives.
Additional resources:
Access Telehealth Practice Resources
Recent activity
- AAN Joins Over 200 Organizations on DEA's Special Registration for Telemedicine | Posted July 22, 2025
- AAN Provides Comments to DEA on Telemedicine | Posted March 14, 2025
- AAN Joins Coalition Requesting Full NIH Funding in FY25 and Protection Against Cuts to Reimbursement for NIH Grantees | Posted February 25, 2025